Viscum Album Subcutaneous Injection – A Natural Support in Integrative Oncology

 Viscum album, commonly known as European mistletoe, has been used for decades in integrative oncology, particularly in Europe. ABNOBA GmbH, a research-driven pharmaceutical company based in Pforzheim, Germany, has pioneered the production of high-quality viscum album extracts for therapeutic use. Through ABNOBA India, these extracts are now available to support cancer care across the Indian medical landscape.

The viscum album subcutaneous injection is a standardized herbal preparation made from specially harvested mistletoe plants. When administered under the skin (subcutaneously), this preparation stimulates the immune system, enhances quality of life, and may help reduce side effects of conventional therapies like chemotherapy and radiation.

Scientific research and clinical practice suggest that viscum album injections can activate immune responses by increasing the activity of natural killer (NK) cells and cytotoxic T lymphocytes. Patients often report improved energy levels, appetite, and emotional well-being during mistletoe therapy. Importantly, it can be used as a complementary treatment alongside conventional oncology regimens, without interfering with their efficacy.

ABNOBA’s unique manufacturing process ensures batch-to-batch consistency, purity, and efficacy, making their products trusted by physicians and integrative oncology practitioners worldwide.

In India, more healthcare professionals are embracing viscum album therapy to offer holistic, patient-centered cancer care. ABNOBA India provides access to the full ABNOBAvisc® product line, along with educational support for clinicians.

To learn more, visit www.abnoba.in and explore how viscum album subcutaneous injections can become a powerful ally in integrative oncology.



Comments

Post a Comment

Popular posts from this blog

Exploring the Healing Potential of Mistletoe Therapy in Cancer Care

Image
 Mistletoe therapy, long integrated into European oncology practices, is gaining global recognition for its ability to enhance the overall well-being of cancer patients. Manufactured by ABNOBA GmbH , a leading German research-based pharmaceutical company, mistletoe extracts are now accessible in India through ABNOBA India , bringing a powerful complementary approach to supportive cancer care. Unlike conventional treatments that directly target tumors, mistletoe therapy works by stimulating the body’s own defenses . Its active ingredients, including mistletoe lectins , help activate immune cells and regulate the immune response—crucial during cancer treatment, when immunity is often compromised. One of mistletoe therapy’s most appreciated benefits is its impact on quality of life . Clinical studies have shown that patients receiving mistletoe extracts often report reduced treatment-related fatigue , nausea , and emotional distress , leading to better energy levels and a more stabl...
Read more

Unlocking the Healing Potential of Mistletoe Extracts in Modern Medicine

Image
Mistletoe ( Viscum album ) is more than just a symbol of tradition—it holds immense therapeutic promise in the field of integrative oncology. For decades, mistletoe extracts have been utilized in Europe, particularly in German-speaking countries, as a supportive treatment for cancer patients. Their role in enhancing immune function, improving tolerance to chemotherapy, and increasing overall well-being is well documented through scientific and clinical research. ABNOBA GmbH , a reputable German pharmaceutical company based in Pforzheim, is a pioneer in the development and production of standardized mistletoe extracts. With a commitment to scientific rigor and patient safety, ABNOBA ensures that its products maintain high levels of purity, consistency, and efficacy. Through ABNOBA India, these advanced therapies are now accessible to a wider patient base in South Asia, bridging the gap between traditional European therapies and modern Indian medical practices. The therapeutic compoun...
Read more

Scientific Evidence Supporting Mistletoe Therapy in Oncology

Image
Mistletoe therapy, derived from the European mistletoe plant ( Viscum album ), has gained attention as a complementary treatment in oncology, particularly in German-speaking countries. ABNOBA GmbH, a research-driven pharmaceutical company based in Pforzheim, Germany, has been at the forefront of developing standardized mistletoe extracts used in integrative cancer care. Scientific investigations over the past few decades have supported the potential benefits of mistletoe therapy in cancer treatment . Preclinical studies indicate that mistletoe extracts possess immunomodulatory, apoptotic (cell death-inducing), and cytotoxic effects against various tumor cell lines. These properties are largely attributed to mistletoe lectins and viscotoxins, key bioactive compounds in the extract. Clinical research, including randomized controlled trials, has shown that mistletoe therapy can improve quality of life, reduce chemotherapy side effects such as fatigue and nausea, and possibly extend surv...
Read more